SCHEMBL7765688

SCHEMBL7765688

COc1ccccc1Sc1nc(N)nc2c1ncn2CCOC(P)(CC(F)(F)F)CC(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 2/20 0.41
DHFR P00374 2/20 0.39
ADORA2A P29274 1/20 0.37
CYP1A2 P05177 4/20 0.37
CYP2C19 P33261 4/20 0.37
CYP2C9 P11712 3/20 0.37
HIF1A Q16665 3/20 0.37
CYP3A4 P08684 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PHLPP2 Q6ZVD8 1/20 0.37
HSP90B1 P14625 1/20 0.36
CYP2D6 P10635 2/20 0.36
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
HSP90AA1 P07900 2/20 0.34
HSP90AB1 P08238 2/20 0.34
PPP1CA P62136 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HK1 P19367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7765668 0.86 SLC29A1 (0.43) SLC29A1ADORA2ACYP1A2CYP2C19CYP2C9
SCHEMBL6838428 0.84 NSD3 (0.40) SLC29A1DHFRADORA2ACYP1A2CYP2C19
SCHEMBL7769278 0.83 DHFR (0.41) SLC29A1DHFRADORA2ACYP1A2CYP2C19
SCHEMBL7125916 0.83 SLC29A1 (0.39) SLC29A1DHFRADORA2ACYP1A2CYP2C19
SCHEMBL7769652 0.83 SLC29A1 (0.43) SLC29A1DHFRADORA2ACYP1A2CYP2C19
SCHEMBL7596236 0.82 SLC29A1 (0.39) SLC29A1DHFRCYP1A2CYP2C19CYP2C9
SCHEMBL7123661 0.82 DHFR (0.40) SLC29A1DHFRADORA2ACYP1A2CYP2C19
Hydrochloric Acid SCHEMBL7770986 0.81 DHFR (0.40) SLC29A1DHFRADORA2ACYP1A2CYP2C19
SCHEMBL7898352 0.81 CYP2C19 (0.47) SLC29A1CYP1A2CYP2C19CYP2C9HIF1A
SCHEMBL15532061 0.80 SLC29A1 (0.40) SLC29A1DHFRCYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846788-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN Akron Molecules AG (AT) 2015-03-18 EP disclosed
WO-2013167743-A1 USE OF COMPOUNDS FOR THE TREATMENT OF PAIN AKRON MOLECULES GMBH (AT) 2013-11-14 WO disclosed
EP-0785208-B1 Phosphonate nucleotide compounds MITSUBISHI CHEM CORP (JP) 2001-03-21 EP disclosed
EP-0785208-A1 Phosphonate nucleotide compounds MITSUBISHI CHEMICAL CORPORATION (JP) 1997-07-23 EP disclosed